Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Evaluation of Aortic-Radial Blood Pressure Gradient in Pediatric Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass (GARP)

29 de septiembre de 2026 actualizado por: Pontificia Universidad Catolica de Chile

Invasive blood pressure monitoring is essential during heart surgery. Usually, doctors measure blood pressure using a small tube (a catheter) placed in an artery, typically in the wrist or arm. During surgeries that require a heart-lung machine (cardiopulmonary bypass), doctors can also measure blood pressure directly near the heart in the main artery (the aorta). This is done using a tube already in place for the machine, so no extra procedure is needed.

In adult patients, doctors have noticed that blood pressure readings taken at the arm can sometimes be significantly different from readings taken near the heart right after coming off the heart-lung machine. This difference could lead to unnecessary or incorrect treatments if medical teams rely only on arm readings. However, it is still unknown whether this same difference occurs in children.

The goal of this study is to measure and compare blood pressure from both the arm and near the heart in children aged 3 years and younger as they come off the heart-lung machine during heart surgery. This research will help medical teams make safer, more accurate treatment decisions for children undergoing heart surgery.

Descripción general del estudio

Descripción detallada

Accurate arterial blood pressure monitoring is essential during and after cardiopulmonary bypass (CPB) in pediatric cardiac surgery. However, a significant gradient between radial and central aortic pressure has been reported, which could lead to erroneous clinical decisions if radial pressure is overestimated. Although this phenomenon has been studied in adults, its incidence, associated factors, and clinical implications in pediatric patients under 3 years of age remain to be clearly established.

This study proposes a prospective observational cohort design including 100 patients under 3 years of age undergoing cardiac surgery with CPB and invasive radial arterial monitoring. The study will evaluate the incidence of a significant radial-to-aortic gradient (defined as a >20% difference in SBP or >10% in MAP sustained for more than 5 minutes), alongside biometric and surgical risk factors, and its relationship with clinical outcomes such as vasoactive drug requirements, blood transfusions, and duration of mechanical ventilation.

Statistical analysis will be performed using descriptive statistics, bivariate testing, and multivariate LASSO logistic regression. This study is expected to identify a pediatric risk profile for developing a significant pressure gradient, thereby optimizing decision-making regarding arterial monitoring sites and post-CPB hemodynamic management. Ultimately, this research aims to address a clinically relevant knowledge gap and enhance perioperative safety in this highly vulnerable population.

Tipo de estudio

De observación

Inscripción (Estimado)

100

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Santiago Arze, MD
  • Número de teléfono: +56955049217
  • Correo electrónico: sarze@uc.cl

Copia de seguridad de contactos de estudio

  • Nombre: Valeria Pizarro, MD
  • Número de teléfono: +56962283715
  • Correo electrónico: vale.pizarro@uc.cl

Ubicaciones de estudio

    • Santiago Metropolitan
      • Santiago, Santiago Metropolitan, Chile, 8320000
        • Reclutamiento
        • Pontificia Universidad Católica de Chile
      • Santiago, Santiago Metropolitan, Chile, 8320000
        • Reclutamiento
        • Red de Salud UC Christus

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

1 segundo a 3 años (Niño)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Pediatric patients from 0-3 years of age

Descripción

Inclusion Criteria:

  • Patients from 0 to 3 years old
  • Cardiac surgery with cardiopulmonary bypass (CPB)
  • Invasive blood pressure monitoring via radial artery

Exclusion Criteria:

  • Patients in whom radial cannulation is not achieved
  • Significant vascular malformations that may interfere with or contraindicate invasive radial blood pressure measurement
  • Emergency surgeries
  • Reinterventions during the same hospital stay
  • Technical complications preventing reliable direct aortic pressure measurement

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: PROSPECTIVE

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Study group

Patients under 3 years of age undergoing cardiac surgery with cardiopulmonary bypass (CPB) at the UC-Christus Clinical Hospital.

Placement of a pressure transducer at the accessory port of the cardiopulmonary bypass (CPB) arterial cannula during the final phase of CPB and the immediate post-CPB period.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
To evaluate the occurrence of a significant radial-to-aortic (R-Ao) pressure gradient during the immediate post-cardiopulmonary bypass (CPB) period
Periodo de tiempo: within 15 minutes from the weaning of the CBP

A significant radial-to-aortic (R-Ao) pressure gradient is defined as a >20% difference in SBP or >10% difference in MAP sustained for >5 minutes) during the immediate post-cardiopulmonary bypass (CPB) period

within 15 minutes from the weaning of the CBP

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
To determine the incidence of the R-Ao gradient in pediatric patients undergoing cardiac surgery with CPB and compare it with reported rates in the adult literature.
Periodo de tiempo: Within the first 15 minutes after CPB weaning.

R-Ao Gradient Incidence: percentage of positive finding to the total of recruited patients in the study.

Reported Rates in adult population: As per an exhaustive review of previous literature.

Within the first 15 minutes after CPB weaning.
To identify risk factors associated with a higher R-Ao gradient, based on patient biometric parameters and surgical variables
Periodo de tiempo: From enrollment to 48 hours after surgery

Patient variables: age, body surface area [BSA], radial artery diameter Surgery variables: CPB duration and use of hypothermia Outcome Measure: Odds Ratio

From enrollment to 48 hours after surgery
To compare vasoactive drug requirements/dosages between patients with and without a significant arterial gradient
Periodo de tiempo: within 30 minutes from the weaning of the CBP, up to 48 hours after surgery.

The comparison will be made using VIS score, as:

VIS = dopamine + dobutamine + (100 × epinephrine) + (100 × norepinephrine) + (10 × milrinone) + (10,000 × vasopressin)

It will be measured at three time periods: 30 mins post CPB, Postoperative Day 1 and Postoperative Day 2

within 30 minutes from the weaning of the CBP, up to 48 hours after surgery.
To compare the duration of invasive mechanical ventilation between patients with and without a significant arterial gradient.
Periodo de tiempo: within the first 48 hours following weaning of the CBP
within the first 48 hours following weaning of the CBP
To compare the incidence of post-CPB blood transfusion between patients with and without a significant arterial gradient.
Periodo de tiempo: within the first 48 hours following weaning of the CBP
within the first 48 hours following weaning of the CBP
To compare the incidence of renal dysfunction between patients with and without a significant arterial gradient.
Periodo de tiempo: within 48 hours following weaning of the CBP
within 48 hours following weaning of the CBP

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Santiago Arze, MD, División de Anestesiología, Pontificia Universidad Católica de Chile

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

20 de abril de 2026

Finalización primaria (Actual)

20 de abril de 2026

Finalización del estudio (Estimado)

21 de abril de 2028

Fechas de registro del estudio

Enviado por primera vez

29 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

29 de septiembre de 2026

Publicado por primera vez (Actual)

5 de octubre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

5 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

29 de septiembre de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 250425011

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir